Skip to main content

Table 1 Clinical and pathological characteristics of the patients

From: Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer

 

All (67)

CRC (58)

Gender

 Male

47

41

 Female

20

17

Age

61.7 ± 10.9

62.8 ± 9.8

Location

 Colon

31

28

 Rectum

32

30

 Stomach

4

 

Pathology

 Adenocarcinoma

61

58

 GIST

1

 

 Non-malignant

5

 

 Differentiation

  

 Moderately

33

32

 Poorly

13

11

 Mucinous

4

4

Stage

 0

1

1

 I

7

7

 II

16

16

 III

20

19

 IV

17

15

 Other

6

 
  1. CRC colorectal cancer